Indian regulators have taken action against Sun Pharma, the largest drugmaker in the country. The company is now barred from producing ophthalmic drugs at its factory located in Assam. This restriction will remain in place until the company provides a compliance report that regulators find satisfactory. The decision follows reports of quality lapses at the plant.